Bill Lis is the founder of Tr1x. Tr1x has raised $75M in total funding. Latest round: Series A. Backed by The Column Group, NEVA SGR, Alexandria Ventures.
Bill Lis is the former CEO and current Executive Chairman of Tr1X, a biotechnology company developing cell therapies for autoimmune and inflammatory diseases. He led the company through its emergence from stealth with a $75 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library